Purchases and Sales Made in Q4 2021 in Phasebio Pharmaceuticals Inc C (PHASQ)
This table provides information about the institutional ownership of Phasebio Pharmaceuticals Inc C (PHASQ) during Q4 2021. The information is specifically focused on institutions that hold shares of PHASEBIO PHARMACEUTICALS INC C.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2022
Q4 2021
|
Dafna Capital Management LLC
Los Angeles, CA |
SELL
|
- |
-224K- 37.22% |
N/A
|
379K
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Caas Capital Management LP
New York, NY |
SELL
|
- |
-263KClosed |
N/A
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-300KClosed |
N/A
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Endurant Capital Management LP
San Mateo, CA |
SELL
|
- |
-772K- 68.21% |
N/A
|
360K
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Altium Capital Management LP
New York, NY |
SELL
|
- |
-775KClosed |
N/A
|
0
$0
|
|
|
Feb 10, 2022
Q4 2021
|
Candriam S.C.A.
|
SELL
|
- |
-1.08MClosed |
N/A
|
0
$0
|
|
|
Feb 11, 2022
Q4 2021
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-1.16M- 28.7% |
N/A
|
2.87M
$0
|